The DOI matches its Crossref record.
Effect of Increased Expression of Protein Disulfide Isomerase and Heavy Chain Binding Protein on Antibody Secretion in a Recombinant CHO Cell Line
Abstract
Previous work has shown that a human-antibody-producing recombinant CHO cell line did not increase its intracellular content of protein disulfide isomerase (PDI) and heavy chain binding protein (BIP) according to the increasing expression of antibody. It was also found that the intracellular assembly of light and heavy chain is a major limiting factor for overall cell specific productivity, as secretion rates improve with higher light chain expression levels and heavy chain accumulates intracellularly when too little light chain is present. As these CHO cells had a significantly lower intracellular PDI content compared to that of hybridoma cells, these results have led us to try to overcome the limitation in the posttranslational assembly in the endoplasmatic reticulum. Recombinant CHO cells were transfected with PDI or BIP alone or in combination, and the effect on intracellular light and heavy chain content and specific production rate was determined. Overexpression of BIP, both alone and in combination with PDI, reduced the specific secretion rate, whereas PDI, when overexpressed alone, caused an increase of product secretion rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Post-translational modifications in the context of therapeutic proteins
Walsh, G., & Jefferis, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1252 · Cited by 1,005
Kim, J. Y., Kim, Y.-G., & Lee, G. M. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3758-5 · Cited by 801
Advances in recombinant antibody manufacturing
Kunert, R., & Reinhart, D. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7388-9 · Cited by 417
Self-citationGasser, B., Saloheimo, M., Rinas, U., Dragosits, M., Rodríguez-Carmona, E., Baumann, K., Giuliani, M., Parrilli, E., Branduardi, P., Lang, C., et al. (2008) · Microbial Cell Factories · doi:10.1186/1475-2859-7-11 · Cited by 326
Self-citationThe art of CHO cell engineering: A comprehensive retrospect and future perspectives
Fischer, S., Handrick, R., & Otte, K. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.10.015 · Cited by 312
Guidelines to cell engineering for monoclonal antibody production
Rita Costa, A., Elisa Rodrigues, M., Henriques, M., Azeredo, J., & Oliveira, R. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.10.002 · Cited by 178
An Adaptable Standard for Protein Export from the Endoplasmic Reticulum
Wiseman, R. L., Powers, E. T., Buxbaum, J. N., Kelly, J. W., & Balch, W. E. (2007) · Cell · doi:10.1016/j.cell.2007.10.025 · Cited by 155
CHO cell engineering to prevent polypeptide aggregation and improve therapeutic protein secretion
Le Fourn, V., Girod, P.-A., Buceta, M., Regamey, A., & Mermod, N. (2014) · Metabolic Engineering · doi:10.1016/j.ymben.2012.12.003 · Cited by 144
Assessment of cell engineering strategies for improved therapeutic protein production in CHO cells
Mohan, C., Kim, Y., Koo, J., & Lee, G. M. (2008) · Biotechnology Journal · doi:10.1002/biot.200700249 · Cited by 102
“While PDI overexpression alone increased the q, PDI overexpression along with immunoglobulin heavy chain-binding protein (BiP) decreased the q for a human antibody producing recombinant CHO cell line [40].”
BackgroundMohan, C., Park, S. H., Chung, J. Y., & Lee, G. M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21453 · Cited by 73
“On the other hand, qAb was found to be improved by 15–27%, which was comparable to the previous reported increment of 37% (Borth et al., 2005).”
BackgroundResultInfluentialDifferential effect of exocytic SNAREs on the production of recombinant proteins in mammalian cells
Peng, R., Abellan, E., & Fussenegger, M. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.22986 · Cited by 61
Florin, L., Pegel, A., Becker, E., Hausser, A., Olayioye, M. A., & Kaufmann, H. (2009) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2009.02.014 · Cited by 59
Ha, T. K., Hansen, A. H., Kildegaard, H. F., & Lee, G. M. (2019) · Biotechnology Journal · doi:10.1002/biot.201900130 · Cited by 30
Rahimpour, A. (2013) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1302.02035 · Cited by 30
Metadata
- Authors
- Borth, N., Mattanovich, D., Kunert, R., & Katinger, H.
- Venue
- Biotechnology Progress
- Publisher
- Wiley
- Published
- 2008-09-05
- Volume
- 21
- Issue
- 1
- Pages
- 106-111
- ISSN
- 1520-6033 (ISSN-L)
- 8756-7938
- OpenAlex
- W2131566517
- Cited by
- 190
- References
- 0
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.